Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Plos One|November 4, 2014
Bioartificial heart: a human-sized porcine model--the way aheadAlexander Weymann, Nikhil Prakash Patil, Anton Sabashnikov, et al.Clinical Chemistry|February 9, 2008
Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestationsMaria Papp, Ildiko Foldi, Eva Nemes, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2017
Prostaglandin E2 Increases Lentiviral Vector Transduction Efficiency of Adult Human Hematopoietic Stem and Progenitor CellsGarrett C Heffner, Melissa Bonner, Lauryn Christiansen, et al.Molecular Therapy. Methods & Clinical Development|April 18, 2020
Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene TherapyChristian Brendel, Olivier Negre, Michael Rothe, et al.Inflammatory Bowel Diseases|April 10, 2007
Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patientsMaria Papp, Istvan Altorjay, Gary L Norman, et al.Alimentary Pharmacology & Therapeutics|November 20, 2018
Response to treatment is more important than disease severity at diagnosis for prediction of early relapse in new-onset paediatric Crohn's diseaseTomer Ziv-Baran, Séamus Hussey, Malgorzata Sladek, et al.Journal of Crohn'S & Colitis|November 23, 2017
Differences in Outcomes Over Time With Exclusive Enteral Nutrition Compared With Steroids in Children With Mild to Moderate Crohn's Disease: Results From the GROWTH CD StudyNoa Cohen-Dolev, Malgorata Sladek, Seamus Hussey, et al.European Journal of Gastroenterology & Hepatology|July 17, 2010
Frequency and risk factors of gastric and duodenal ulcers or erosions in children: a prospective 1-month European multicenter studyNicolas Kalach, Patrick Bontems, Sibylle Koletzko, et al.Current Gene Therapy|November 28, 2014
Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell diseaseOlivier Negre, Cynthia Bartholomae, Yves Beuzard, et al.Journal of Pediatric Gastroenterology and Nutrition|November 16, 2013
ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescentsArie Levine, Sibylle Koletzko, Dan Turner, et al.Pageof 9